ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 907 filers reported holding ASTRAZENECA PLC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $7,209 | -46.8% | 106,459 | -47.1% | 0.11% | -50.0% |
| Q4 2023 | $13,562 | -10.6% | 201,370 | -5.1% | 0.22% | -11.8% |
| Q2 2023 | $15,177 | +2.3% | 212,093 | -0.8% | 0.24% | -5.4% |
| Q1 2023 | $14,843 | -57.1% | 213,850 | -58.1% | 0.26% | -17.0% |
| Q4 2022 | $34,580 | -99.8% | 510,106 | +55.9% | 0.31% | -14.0% |
| Q3 2022 | $17,938,000 | -17.0% | 327,270 | 0.0% | 0.36% | -10.8% |
| Q2 2022 | $21,623,000 | -23.3% | 327,270 | -23.0% | 0.41% | -2.2% |
| Q1 2022 | $28,192,000 | +13.9% | 425,093 | 0.0% | 0.42% | +30.4% |
| Q4 2021 | $24,749,000 | -6.1% | 425,093 | -3.1% | 0.32% | -14.9% |
| Q3 2021 | $26,350,000 | +0.3% | 438,802 | 0.0% | 0.38% | +0.5% |
| Q2 2021 | $26,280,000 | -51.0% | 438,802 | -59.2% | 0.37% | -5.8% |
| Q1 2021 | $53,680,000 | +75.8% | 1,076,544 | +76.2% | 0.40% | -11.4% |
| Q4 2020 | $30,534,000 | – | 610,915 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |